HOLLY BRUNO: Open Payments
NPI 1407533623 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $746 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $72 |
| Exact Sciences Corporation | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Lundbeck LLC | 2 | $45 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $18 |
Products named: JARDIANCE, CAPLYTA, VRAYLAR, REXULTI, AIRSUPRA, Cologuard Collection Kit, FARXIGA, VYEPTI.
Industry payments across TX — which companies pay providers there.
